Microbiome Therapeutics Market - Global Outlook and Forecast 2021-2027

March 2021 | 112 pages | ID: M077541D1361EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Microbiome Therapeutics in Global, including the following market information:

Global Microbiome Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Microbiome Therapeutics market was valued at 62 million in 2020 and is projected to reach US$ 191.6 million by 2027, at a CAGR of 32.7% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microbiome Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Microbiome Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Microbiome Therapeutics Market Segment Percentages, By Type, 2020 (%)

• Upper GIT
• Lower GIT

China Microbiome Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Microbiome Therapeutics Market Segment Percentages, By Application, 2020 (%)

• Inflammatory Bowel Disease (IBD)
• Orphan Drug
• Immuno-Oncology
• Others

Global Microbiome Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Microbiome Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Microbiome Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Microbiome Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Seres Therapeutics
• Assembly Biosciences
• Synthetic Biologics
• Interxon
• PureTech
• Synlogic
• Enterome BioScience
• 4D Pharma
• Second Genome
• AOBiome
• C3 Jian
• Rebiotix
• MicroBiome Therapeutics LLC
• Metabiomics
• Ritter Pharmaceuticals
• Symberix
• OpenBiome
• Azitra
• Symbiotix Biotherapies
• Osel
• Metabogen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Microbiome Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Microbiome Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MICROBIOME THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Microbiome Therapeutics Market Size: 2021 VS 2027
2.2 Global Microbiome Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Microbiome Therapeutics Players in Global Market
3.2 Top Global Microbiome Therapeutics Companies Ranked by Revenue
3.3 Global Microbiome Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Microbiome Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Microbiome Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Microbiome Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Microbiome Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Microbiome Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Microbiome Therapeutics Market Size Markets, 2021 & 2027
  4.1.2 Upper GIT
  4.1.3 Lower GIT
4.2 By Type - Global Microbiome Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Microbiome Therapeutics Revenue, 2016-2021
  4.2.2 By Type - Global Microbiome Therapeutics Revenue, 2022-2027
  4.2.3 By Type - Global Microbiome Therapeutics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Microbiome Therapeutics Market Size, 2021 & 2027
  5.1.2 Inflammatory Bowel Disease (IBD)
  5.1.3 Orphan Drug
  5.1.4 Immuno-Oncology
  5.1.5 Others
5.2 By Application - Global Microbiome Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Microbiome Therapeutics Revenue, 2016-2021
  5.2.2 By Application - Global Microbiome Therapeutics Revenue, 2022-2027
  5.2.3 By Application - Global Microbiome Therapeutics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Microbiome Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Microbiome Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Microbiome Therapeutics Revenue, 2016-2021
  6.2.2 By Region - Global Microbiome Therapeutics Revenue, 2022-2027
  6.2.3 By Region - Global Microbiome Therapeutics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Microbiome Therapeutics Revenue, 2016-2027
  6.3.2 US Microbiome Therapeutics Market Size, 2016-2027
  6.3.3 Canada Microbiome Therapeutics Market Size, 2016-2027
  6.3.4 Mexico Microbiome Therapeutics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Microbiome Therapeutics Revenue, 2016-2027
  6.4.2 Germany Microbiome Therapeutics Market Size, 2016-2027
  6.4.3 France Microbiome Therapeutics Market Size, 2016-2027
  6.4.4 U.K. Microbiome Therapeutics Market Size, 2016-2027
  6.4.5 Italy Microbiome Therapeutics Market Size, 2016-2027
  6.4.6 Russia Microbiome Therapeutics Market Size, 2016-2027
  6.4.7 Nordic Countries Microbiome Therapeutics Market Size, 2016-2027
  6.4.8 Benelux Microbiome Therapeutics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Microbiome Therapeutics Revenue, 2016-2027
  6.5.2 China Microbiome Therapeutics Market Size, 2016-2027
  6.5.3 Japan Microbiome Therapeutics Market Size, 2016-2027
  6.5.4 South Korea Microbiome Therapeutics Market Size, 2016-2027
  6.5.5 Southeast Asia Microbiome Therapeutics Market Size, 2016-2027
  6.5.6 India Microbiome Therapeutics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Microbiome Therapeutics Revenue, 2016-2027
  6.6.2 Brazil Microbiome Therapeutics Market Size, 2016-2027
  6.6.3 Argentina Microbiome Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Microbiome Therapeutics Revenue, 2016-2027
  6.7.2 Turkey Microbiome Therapeutics Market Size, 2016-2027
  6.7.3 Israel Microbiome Therapeutics Market Size, 2016-2027
  6.7.4 Saudi Arabia Microbiome Therapeutics Market Size, 2016-2027
  6.7.5 UAE Microbiome Therapeutics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Seres Therapeutics
  7.1.1 Seres Therapeutics Corporate Summary
  7.1.2 Seres Therapeutics Business Overview
  7.1.3 Seres Therapeutics Microbiome Therapeutics Major Product Offerings
  7.1.4 Seres Therapeutics Microbiome Therapeutics Revenue in Global (2016-2021)
  7.1.5 Seres Therapeutics Key News
7.2 Assembly Biosciences
  7.2.1 Assembly Biosciences Corporate Summary
  7.2.2 Assembly Biosciences Business Overview
  7.2.3 Assembly Biosciences Microbiome Therapeutics Major Product Offerings
  7.2.4 Assembly Biosciences Microbiome Therapeutics Revenue in Global (2016-2021)
  7.2.5 Assembly Biosciences Key News
7.3 Synthetic Biologics
  7.3.1 Synthetic Biologics Corporate Summary
  7.3.2 Synthetic Biologics Business Overview
  7.3.3 Synthetic Biologics Microbiome Therapeutics Major Product Offerings
  7.3.4 Synthetic Biologics Microbiome Therapeutics Revenue in Global (2016-2021)
  7.3.5 Synthetic Biologics Key News
7.4 Interxon
  7.4.1 Interxon Corporate Summary
  7.4.2 Interxon Business Overview
  7.4.3 Interxon Microbiome Therapeutics Major Product Offerings
  7.4.4 Interxon Microbiome Therapeutics Revenue in Global (2016-2021)
  7.4.5 Interxon Key News
7.5 PureTech
  7.5.1 PureTech Corporate Summary
  7.5.2 PureTech Business Overview
  7.5.3 PureTech Microbiome Therapeutics Major Product Offerings
  7.5.4 PureTech Microbiome Therapeutics Revenue in Global (2016-2021)
  7.5.5 PureTech Key News
7.6 Synlogic
  7.6.1 Synlogic Corporate Summary
  7.6.2 Synlogic Business Overview
  7.6.3 Synlogic Microbiome Therapeutics Major Product Offerings
  7.6.4 Synlogic Microbiome Therapeutics Revenue in Global (2016-2021)
  7.6.5 Synlogic Key News
7.7 Enterome BioScience
  7.7.1 Enterome BioScience Corporate Summary
  7.7.2 Enterome BioScience Business Overview
  7.7.3 Enterome BioScience Microbiome Therapeutics Major Product Offerings
  7.4.4 Enterome BioScience Microbiome Therapeutics Revenue in Global (2016-2021)
  7.7.5 Enterome BioScience Key News
7.8 4D Pharma
  7.8.1 4D Pharma Corporate Summary
  7.8.2 4D Pharma Business Overview
  7.8.3 4D Pharma Microbiome Therapeutics Major Product Offerings
  7.8.4 4D Pharma Microbiome Therapeutics Revenue in Global (2016-2021)
  7.8.5 4D Pharma Key News
7.9 Second Genome
  7.9.1 Second Genome Corporate Summary
  7.9.2 Second Genome Business Overview
  7.9.3 Second Genome Microbiome Therapeutics Major Product Offerings
  7.9.4 Second Genome Microbiome Therapeutics Revenue in Global (2016-2021)
  7.9.5 Second Genome Key News
7.10 AOBiome
  7.10.1 AOBiome Corporate Summary
  7.10.2 AOBiome Business Overview
  7.10.3 AOBiome Microbiome Therapeutics Major Product Offerings
  7.10.4 AOBiome Microbiome Therapeutics Revenue in Global (2016-2021)
  7.10.5 AOBiome Key News
7.11 C3 Jian
  7.11.1 C3 Jian Corporate Summary
  7.11.2 C3 Jian Business Overview
  7.11.3 C3 Jian Microbiome Therapeutics Major Product Offerings
  7.11.4 C3 Jian Microbiome Therapeutics Revenue in Global (2016-2021)
  7.11.5 C3 Jian Key News
7.12 Rebiotix
  7.12.1 Rebiotix Corporate Summary
  7.12.2 Rebiotix Business Overview
  7.12.3 Rebiotix Microbiome Therapeutics Major Product Offerings
  7.12.4 Rebiotix Microbiome Therapeutics Revenue in Global (2016-2021)
  7.12.5 Rebiotix Key News
7.13 MicroBiome Therapeutics LLC
  7.13.1 MicroBiome Therapeutics LLC Corporate Summary
  7.13.2 MicroBiome Therapeutics LLC Business Overview
  7.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Major Product Offerings
  7.13.4 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue in Global (2016-2021)
  7.13.5 MicroBiome Therapeutics LLC Key News
7.14 Metabiomics
  7.14.1 Metabiomics Corporate Summary
  7.14.2 Metabiomics Business Overview
  7.14.3 Metabiomics Microbiome Therapeutics Major Product Offerings
  7.14.4 Metabiomics Microbiome Therapeutics Revenue in Global (2016-2021)
  7.14.5 Metabiomics Key News
7.15 Ritter Pharmaceuticals
  7.15.1 Ritter Pharmaceuticals Corporate Summary
  7.15.2 Ritter Pharmaceuticals Business Overview
  7.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Major Product Offerings
  7.15.4 Ritter Pharmaceuticals Microbiome Therapeutics Revenue in Global (2016-2021)
  7.15.5 Ritter Pharmaceuticals Key News
7.16 Symberix
  7.16.1 Symberix Corporate Summary
  7.16.2 Symberix Business Overview
  7.16.3 Symberix Microbiome Therapeutics Major Product Offerings
  7.16.4 Symberix Microbiome Therapeutics Revenue in Global (2016-2021)
  7.16.5 Symberix Key News
7.17 OpenBiome
  7.17.1 OpenBiome Corporate Summary
  7.17.2 OpenBiome Business Overview
  7.17.3 OpenBiome Microbiome Therapeutics Major Product Offerings
  7.17.4 OpenBiome Microbiome Therapeutics Revenue in Global (2016-2021)
  7.17.5 OpenBiome Key News
7.18 Azitra
  7.18.1 Azitra Corporate Summary
  7.18.2 Azitra Business Overview
  7.18.3 Azitra Microbiome Therapeutics Major Product Offerings
  7.18.4 Azitra Microbiome Therapeutics Revenue in Global (2016-2021)
  7.18.5 Azitra Key News
7.19 Symbiotix Biotherapies
  7.19.1 Symbiotix Biotherapies Corporate Summary
  7.19.2 Symbiotix Biotherapies Business Overview
  7.19.3 Symbiotix Biotherapies Microbiome Therapeutics Major Product Offerings
  7.19.4 Symbiotix Biotherapies Microbiome Therapeutics Revenue in Global (2016-2021)
  7.19.5 Symbiotix Biotherapies Key News
7.20 Osel
  7.20.1 Osel Corporate Summary
  7.20.2 Osel Business Overview
  7.20.3 Osel Microbiome Therapeutics Major Product Offerings
  7.20.4 Osel Microbiome Therapeutics Revenue in Global (2016-2021)
  7.20.5 Osel Key News
7.21 Metabogen
  7.21.1 Metabogen Corporate Summary
  7.21.2 Metabogen Business Overview
  7.21.3 Metabogen Microbiome Therapeutics Major Product Offerings
  7.21.4 Metabogen Microbiome Therapeutics Revenue in Global (2016-2021)
  7.21.5 Metabogen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Microbiome Therapeutics Market Opportunities & Trends in Global Market
Table 2. Microbiome Therapeutics Market Drivers in Global Market
Table 3. Microbiome Therapeutics Market Restraints in Global Market
Table 4. Key Players of Microbiome Therapeutics in Global Market
Table 5. Top Microbiome Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Microbiome Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Microbiome Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Microbiome Therapeutics Product Type
Table 9. List of Global Tier 1 Microbiome Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microbiome Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Microbiome Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Microbiome Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Microbiome Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Microbiome Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Microbiome Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Microbiome Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Microbiome Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Microbiome Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Microbiome Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Microbiome Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Microbiome Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Microbiome Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Microbiome Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Microbiome Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Microbiome Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Microbiome Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Microbiome Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Microbiome Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Microbiome Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Seres Therapeutics Corporate Summary
Table 31. Seres Therapeutics Microbiome Therapeutics Product Offerings
Table 32. Seres Therapeutics Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Assembly Biosciences Corporate Summary
Table 34. Assembly Biosciences Microbiome Therapeutics Product Offerings
Table 35. Assembly Biosciences Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Synthetic Biologics Corporate Summary
Table 37. Synthetic Biologics Microbiome Therapeutics Product Offerings
Table 38. Synthetic Biologics Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Interxon Corporate Summary
Table 40. Interxon Microbiome Therapeutics Product Offerings
Table 41. Interxon Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. PureTech Corporate Summary
Table 43. PureTech Microbiome Therapeutics Product Offerings
Table 44. PureTech Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Synlogic Corporate Summary
Table 46. Synlogic Microbiome Therapeutics Product Offerings
Table 47. Synlogic Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Enterome BioScience Corporate Summary
Table 49. Enterome BioScience Microbiome Therapeutics Product Offerings
Table 50. Enterome BioScience Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. 4D Pharma Corporate Summary
Table 52. 4D Pharma Microbiome Therapeutics Product Offerings
Table 53. 4D Pharma Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Second Genome Corporate Summary
Table 55. Second Genome Microbiome Therapeutics Product Offerings
Table 56. Second Genome Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. AOBiome Corporate Summary
Table 58. AOBiome Microbiome Therapeutics Product Offerings
Table 59. AOBiome Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. C3 Jian Corporate Summary
Table 61. C3 Jian Microbiome Therapeutics Product Offerings
Table 62. C3 Jian Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Rebiotix Corporate Summary
Table 64. Rebiotix Microbiome Therapeutics Product Offerings
Table 65. Rebiotix Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 66. MicroBiome Therapeutics LLC Corporate Summary
Table 67. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offerings
Table 68. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 69. Metabiomics Corporate Summary
Table 70. Metabiomics Microbiome Therapeutics Product Offerings
Table 71. Metabiomics Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 72. Ritter Pharmaceuticals Corporate Summary
Table 73. Ritter Pharmaceuticals Microbiome Therapeutics Product Offerings
Table 74. Ritter Pharmaceuticals Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 75. Symberix Corporate Summary
Table 76. Symberix Microbiome Therapeutics Product Offerings
Table 77. Symberix Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 78. OpenBiome Corporate Summary
Table 79. OpenBiome Microbiome Therapeutics Product Offerings
Table 80. OpenBiome Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 81. Azitra Corporate Summary
Table 82. Azitra Microbiome Therapeutics Product Offerings
Table 83. Azitra Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 84. Symbiotix Biotherapies Corporate Summary
Table 85. Symbiotix Biotherapies Microbiome Therapeutics Product Offerings
Table 86. Symbiotix Biotherapies Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 87. Osel Corporate Summary
Table 88. Osel Microbiome Therapeutics Product Offerings
Table 89. Osel Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)
Table 90. Metabogen Corporate Summary
Table 91. Metabogen Microbiome Therapeutics Product Offerings
Table 92. Metabogen Microbiome Therapeutics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Microbiome Therapeutics Segment by Type
Figure 2. Microbiome Therapeutics Segment by Application
Figure 3. Global Microbiome Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Microbiome Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Microbiome Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2020
Figure 8. By Type - Global Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Microbiome Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Microbiome Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Seres Therapeutics Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Assembly Biosciences Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Synthetic Biologics Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Interxon Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. PureTech Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Synlogic Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Enterome BioScience Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. 4D Pharma Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Second Genome Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. AOBiome Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. C3 Jian Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Rebiotix Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Metabiomics Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Ritter Pharmaceuticals Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Symberix Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. OpenBiome Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Azitra Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Symbiotix Biotherapies Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Osel Microbiome Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)